<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2014</study_start_year><condition>Neoplasm Metastasis</condition><condition>Stage I-III Colon Cancer</condition><condition>Liver Neoplasms</condition><condition>Colonic Neoplasms</condition><condition>Stage, Colon Cancer</condition><condition>Stage IV Colon Cancer With Resectable Liver Metastases</condition><disease>Stage I-iii Colon Cancer</disease><disease>Neoplasm Metastasis</disease><disease>Stage Iv Colon Cancer With Resectable Liver Metastases</disease><disease>Liver Neoplasms</disease><disease>Stage, Colon Cancer</disease><disease>Colonic Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2169218</full_dataset_link><location>United States</location><study_start_month>7</study_start_month><keyword>Vitamin D</keyword><keyword>Cholecalciferol</keyword><keyword>Stage IV colon cancer</keyword><keyword>Ergocalciferols</keyword><keyword>Vitamins</keyword><keyword>Resectable liver metastases</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases</name><description>This study seeks to learn more about the vitamin D receptor and its relationship to colon cancer. The Vitamin D receptor is found in colon cancer cells. When Vitamin D binds to the receptor in the cancer cells, it may stop cancer cells from growing abnormally and may cause cancer cell death. Vitamin D has been used in other research studies and information from those other research studies suggests that Vitamin D may help in the treatment of colon cancer.
Participants will receive either high-dose vitamin D or standard-dose vitamin D. The study drug will be given 14-28 days prior to your surgery. The number of days will depend on when the surgery is scheduled.</description><dates><creation>2014-07-15</creation></dates><accession>2169218</accession><cross_references><ClinicalTrials___gov>NCT02172651</ClinicalTrials___gov></cross_references></HashMap>